Relevant bibliographies by topics / Obesity and Associated Comorbidities

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Obesity and Associated Comorbidities'

Author: Grafiati
Published: 5 June 2025
Last updated: 24 June 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Obesity and Associated Comorbidities.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Obesity and Associated Comorbidities"

1

González Arnáiz, E., L. González Roza, B. Pintor De la Maza, I. Cano Rodríguez, and M. Ballesteros Pomar. "Sarcopenic Obesity And Associated Comorbidities." Clinical Nutrition ESPEN 54 (April 2023): 657. http://dx.doi.org/10.1016/j.clnesp.2022.09.582.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Andolfi, Ciro, and P. Marco Fisichella. "Epidemiology of Obesity and Associated Comorbidities." Journal of Laparoendoscopic & Advanced Surgical Techniques 28, no. 8 (2018): 919–24. http://dx.doi.org/10.1089/lap.2018.0380.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Alghamdi, Abdulrhman S., Khalid S. Alwadeai, Mohammed A. Almeshari, et al. "Prevalence of Obesity and Its Associated Comorbidities in Adults with Asthma: A Single-Center Study in Saudi Arabia." Medicina 60, no. 11 (2024): 1785. http://dx.doi.org/10.3390/medicina60111785.

Full text
Abstract:
Background and Objectives: Asthma is associated with several comorbidities, one of which is obesity. The worldwide increase in obesity has been accompanied by a parallel rise in asthma prevalence, with obesity recognized as a significant risk factor for both the development and severity of asthma. Obesity is often linked to various comorbidities, which can complicate asthma management and lead to poorer clinical outcomes. This study aims to investigate the prevalence of obesity and its comorbidities in adults with asthma in a single center in Saudi Arabia, providing an overview of the associated health implications. Materials and Methods: This single-center, retrospective study aimed to assess the prevalence of obesity and other comorbidities in asthma patients. Data were collected from King Khalid University Hospital in Saudi Arabia between July 2023 and December 2023. Results: This study revealed that 72.1% of asthma patients were either obese or overweight. Female patients had significantly higher BMI values compared to males. Our study revealed that 38.21% of female asthma patients (mean age = 57 ± 13.85 years) had comorbidities compared to 24.14% of male asthma patients (mean age = 59 ± 14.02 years). Furthermore, the proportion of obese asthmatic patients with comorbidities was significantly greater than those without comorbidities. Conclusions: This study investigates obesity prevalence and associated comorbidities in adult asthmatics in a single center in Saudi Arabia. The findings reveal a 72.1% rate of obesity and overweight among asthmatic patients, with higher BMI and comorbidity prevalence in females. These results underscore the need for targeted interventions addressing obesity and comorbidities, especially in female asthmatics.
APA, Harvard, Vancouver, ISO, and other styles
4

Amjad, Meshal Allahyani Fatimah Abdullah Alrabeh Hanan Abdullah Alhajji Fatmah Mohsen Alhejji 3. Sameer Ayed Almaghamsi Feras Abdulwahab Alghamdi Zeyad Saad Aljohani Faisal Ali Alghamdi Abdullah Saleh Almuslam Hussain Abdullah Alkhamis Saleh Abdulaziz Abubaker. "MORBIDITY ASSOCIATED WITH OBESITY." INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES 05, no. 12 (2018): 14043–48. https://doi.org/10.5281/zenodo.1845305.

Full text
Abstract:
<strong><em>Introduction:</em></strong> <em>Body mass index (BMI) is the most commonly used parameter for fatness measurement. It is calculated based on weight and length of an individual by dividing the weight -in kilogram- on the squared length in meter (Kg/M2). The normal BMI slightly differ among genders. However, a BMI ranging from 25.0 to 29.9 kg/m2 is defined as adult overweight. Number high as 30 kg/m2 or more is considered to be obesity.</em> <strong><em>Aim of work: </em></strong><em>In this review, we will discuss </em><em>the comorbidities associated with obesity</em> <strong><em>Methodology:</em></strong> <em>We did a systematic search for the comorbidities associated with obesity in the using PubMed search engine (http://www.ncbi.nlm.nih.gov/) and Google Scholar search engine (https://scholar.google.com). All relevant studies were retrieved and discussed. We only included full articles.</em> <strong><em>Conclusions: </em></strong><em>With its burden on the healthcare system and individuals&rsquo; lifestyle, Obesity is an important concern. Believing of obesity as a character flaw has shifted to more in-depth understanding of it is nature as a disease. </em> <em>Obesity is a result of complex interaction between multiple co-variables. Genes, Socioeconomic status, and cultural beliefs, and environmental factors are associated with the development of, and difficulty treating, obesity. </em> <strong>Key words: </strong><em>Morbidity, obesity, risk factors, complications.</em>
APA, Harvard, Vancouver, ISO, and other styles
5

Bouden, S., L. Kharrat, A. Ben Tekaya, et al. "POS1000 COMORBIDITIES ASSOCIATED TO SPONDYLOARTHRITIS." Annals of the Rheumatic Diseases 80, Suppl 1 (2021): 768.2–769. http://dx.doi.org/10.1136/annrheumdis-2021-eular.2929.

Full text
Abstract:
Background:In contrast to other chronic rheumatic diseases such as rheumatoid arthritis, comorbidities associated to spondyloarthritis (SpA) and their impact on disease outcomes are less well studied.Objectives:The aim of our study was to investigate the prevalence of comorbidities among SpA patients and to determine factors influencing their appearance.Methods:We conducted a retrospective study including patients meeting the Assessment of SpondyloArthritis International Society (ASAS) criteria between 2000 and 2020.The following comorbidities were collected: cardiovascular pathologies and their risk factors (smoking, arterial hypertension, diabetes, dyslipidemia and obesity), neoplasms, osteoporosis, depression, infections, gastrointestinal and pulmonary disorders.Results:We included 138 patients. Sixty-eight per cent of them were males. The mean age was 45.73 ± 12.66 years. The mean age at the disease onset was 28.89 ± 12.54 years. The mean CRP was 33.38 ± 39.65 mg/dL. The mean BASDAI and ASDAS-CRP were 4.21 ±2.23 and 3.06 ± 1.26, respectively. The mean BASFI was 4.77 ± 2.58.Sixty patients had at least one comorbidity (43.5%): 53 patients had one comorbidity (38.4%), 21 accumulated two types of comorbidities (15.2%) and 7 patients accumulated three types or more (5%).Osteoporosis was the most frequent comorbidity, it was present in 23.1% of the cases (n=32), followed by tuberculosis 8.7% (n=12), stomach ulcers 5.1% (n=7), pulmonary superinfection 2.9% (n=4), neoplasia 2.2% (n=3) and then depression 1.4% (n=2).Cardiovascular risk factors were noted in 44 patients (31.9%): hypertension (15.9%), diabetes (12.3%), dyslipidemia (9.4%) and obesity (8.7%).Thirty-seven per cent of our patients were smokers.SpA patients with comorbidities were significantly older than those without (50.2±11.07 versus 42.3±12.8 years, p&lt;0.0001).The presence of comorbidities was significantly associated to a higher disease activity evaluated by BASDAI (p=0.005) and ASDAS-CRP (p=0.002). Furthermore, BASFI was significantly higher among patients with comorbidities (5.47±2.38 versus 4.31±2.62, p=0.028).However, no association was found between presence of comorbidities and smocking or CRP.Conclusion:Our results show that more than 40% of our SpA patients presented with at least one comorbidity. Remarkably, the presence of comorbidities was associated with high disease activity, suggesting that that inflammation might promotes comorbidities. For optimal management of SpA, a systemic screening for comorbidities is essential.Disclosure of Interests:None declared.
APA, Harvard, Vancouver, ISO, and other styles
6

Jehan, Shazia, Ferdinand Zizi, Seithikurippu R. Pandi-Perumal, Samy I. McFarlane, Girardin Jean-Louis, and Alyson K Myers. "Energy imbalance: obesity, associated comorbidities, prevention, management and public health implications." Advances in Obesity, Weight Management & Control 10, no. 5 (2020): 146–61. http://dx.doi.org/10.15406/aowmc.2020.10.00321.

Full text
Abstract:
The prevalence of obesity has been continually increasing, as have its associated comorbidities and health care costs. Effective management of obesity and early intervention measures are necessary to overcome this global issue. The responsibility for preventing and managing this global epidemic does not lie solely on an individual, but also on the entire health care system. Policy makers—nationally and globally—must play their roles to solve the issue. In this review article, we examine methods of controlling and managing obesity through interventions, such as a low caloric diet, physical exercise, pharmacological guidance, and bariatric surgical procedures. While health care professionals should educate patients about all available treatment options for severe obesity, bariatric surgical procedures have increased in popularity and are considered very beneficial with outcomes fruitful in managing severe obesity
APA, Harvard, Vancouver, ISO, and other styles
7

Kohrt, Wendy M. "Abdominal obesity and associated cardiovascular comorbidities in the elderly." Coronary Artery Disease 9, no. 8 (1998): 489–94. http://dx.doi.org/10.1097/00019501-199809080-00004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Bulló, Mónica, Patricia Casas-Agustench, Pilar Amigó-Correig, Javier Aranceta, and Jordi Salas-Salvadó. "Inflammation, obesity and comorbidities: the role of diet." Public Health Nutrition 10, no. 10A (2007): 1164–72. http://dx.doi.org/10.1017/s1368980007000663.

Full text
Abstract:
AbstractThe adipocyte metabolism has been shown to change during the fat enlargement process associated to obesity. Several procoagulant proteins such as plasminogen activator inhibitor type 1, tissue factor or factor VII and also inducible nitric oxide synthase show higher expression in adipose tissue of obese people in comparison to lean. This overexpression could explain at least a part of the atherogenic and cardiovascular risk associated with obesity.In addition to cytokine secretion, many other features have been observed to be common to adipocyte and monocyte/macrophage lines: for example, phagocytic and microbicidal activities, and possibly a cellular plasticity of adipose precursors.Overweight and obesity are associated with an increased risk of such metabolic abnormalities as dyslipidemia, hypertension or type 2 diabetes mellitus and cardiovascular diseases, common features of the metabolic syndrome. Initially, insulin resistance or hyperinsulinemia was suggested as the origin of these abnormalities. More recent studies indicate that adipokynes have an important role in obesity-associated metabolic complications, and suggest that chronically elevated local or systemic concentrations of adipokynes contribute to the development of complications associated with obesity and metabolic syndrome.Considering all the evidence relating to diet and inflammation, the best diet for protecting against the metabolic derangements associated with obesity and metabolic syndrome would be high in fibre-rich cereals, fruit, vegetables, fish, virgin olive oil and nuts; moderate in wine; and low in meat, processed meat foods and trans-fatty acids.
APA, Harvard, Vancouver, ISO, and other styles
9

Kleemann, Robert, and Richard Bucala. "Macrophage Migration Inhibitory Factor: Critical Role in Obesity, Insulin Resistance, and Associated Comorbidities." Mediators of Inflammation 2010 (2010): 1–7. http://dx.doi.org/10.1155/2010/610479.

Full text
Abstract:
Obesity is associated with insulin resistance, disturbed glucose homeostasis, low grade inflammation, and comorbidities such as type 2 diabetes and cardiovascular disease. The cytokine macrophage migration inhibitory factor (MIF) is an ubiquitously expressed protein that plays a crucial role in many inflammatory and autoimmune disorders. Increasing evidence suggests that MIF also controls metabolic and inflammatory processes underlying the development of metabolic pathologies associated with obesity. This is a comprehensive summary of our current knowledge on the role of MIF in obesity and obesity-associated comorbidities, based on human clinical data as well as animal models of disease.
APA, Harvard, Vancouver, ISO, and other styles
10

Bairdain, Sigrid, Chueh Lien, Alexander P. Stoffan, Michael Troy, Donald C. Simonson, and Bradley C. Linden. "A Single Institution’s Overweight Pediatric Population and Their Associated Comorbid Conditions." ISRN Obesity 2014 (February 13, 2014): 1–7. http://dx.doi.org/10.1155/2014/517694.

Full text
Abstract:
Background. Obesity studies are often performed on population data. We sought to examine the incidence of obesity and its associated comorbidities in a single freestanding children’s hospital. Methods. We performed a retrospective analysis of all visits to Boston Children’s Hospital from 2000 to 2012. This was conducted to determine the incidence of obesity, morbid obesity, and associated comorbidities. Each comorbidity was modeled independently. Incidence rate ratios were calculated, as well as odds ratios. Results. A retrospective review of 3,185,658 person-years in nonobese, 26,404 person-years in obese, and 25,819 person-years in the morbidly obese was conducted. Annual rates of all major comorbidities were increased in all patients, as well as in our obese and morbidly obese counterparts. Incidence rate ratios (IRR) and odds ratios (OR) were also significantly increased across all conditions for both our obese and morbidly obese patients. Conclusions. These data illustrate the substantial increases in obesity and associated comorbid conditions. Study limitations include (1) single institution data, (2) retrospective design, and (3) administrative undercoding. Future treatment options need to address these threats to longevity and quality of life.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Obesity and Associated Comorbidities"

1

BARBACINI, PIETRO. "IMPACT OF VITAMIN D DEFICIENCY, DYSLIPIDEMIA AND OBESITY ON SERUM LIPIDOMIC PROFILE. SEARCH FOR NEW BIOMARKERS AS EARLY PREDICTORS OF OBESITY-ASSOCIATED COMORBIDITIES." Doctoral thesis, Università degli Studi di Milano, 2020. http://hdl.handle.net/2434/710504.

Full text
Abstract:
Research studies indicate that up to 58% of the world adult population will be overweight or obese by 2030 [1]. Obesity is not only related to food intake, but factors such as lifestyle and genetic background contribute to its onset [3–5]. This disease [2] is commonly associated with vitamin D (Vit. D) deficiency [6,7], and genetic associations have been identified to explain this link [8]; however, differences in dietary intake, sun exposure, or Vit. D metabolism are also involved [9]. Moreover, along with Vit. D deficiency, lipids, and particularly sphingolipids (SLs) as ceramides (Cers) and sphingomyelins (SMs) have been described as involved, not only in increasing inflammation [10,11], but also in the development of cardiovascular disease and type two diabetes [12–14], two common conditions observed in obese subjects. Given the pivotal role of SLs in obesity associated co-morbidities and the association of Vit. D, dyslipidemia and obesity, our study was aimed at profiling circulating SLs in human subjects under these conditions, in order to provide hints for the identification of new biomarkers to be introduced in clinical settings. To define human SLs profile in obesity, dyslipidemia, and Vit. D associated deficiency, sera from 23 normal-weight normolipidemic (NWNL), 46 normal-weight, dyslipidemic, Vit. D deficient (NWDL) and 60 obese dyslipidemic, Vit. D deficient (ODL) Saudi Arabian subjects were analyzed with a dual approach, characterized by the use of two complementary techniques: the HPTLC-Primuline profiling and the LC-MS analysis. Furthermore, to define SLs profiles in the context of human adaptation to high altitude hypoxia, sera from 59 Vit. D deficient dyslipidemic children living at high altitude were analyzed by LC-MS. Children were grouped based on their BMI percentiles in 7 underweight (UW), 30 normal-weight (NW), 13 overweight (OW) and 9 obese (O). SLs profile analysis of NWNL and ODL Saudi Arabian subjects displayed differences in total Cer and total SM caused by dyslipidemia and vitamin D deficiency, whereas specific Cers, and SMs acyl chains characterize obese subjects, only. Gender differences were found in SLs profiles independently from dyslipidemia and Vit. D status. Obesity-associated Cers, SMs, and dihydrosphingomyelins (dhSMs) specific acyl chains were identified in the NWDL vs. ODL comparison independently from dyslipidemia and Vit D status, and are thought to be drivers of increased risk of developing obesity-associated morbidities. The analysis of SLs profiles from dyslipidemic children with Vit. D deficiency allowed to confirm the results of Saudi Arabian subjects regarding SLs association with dyslipidemia and associated Vit. D deficiency. Furthermore, SLs profile analysis led to the identification of a characteristic SLs portraits associated with BMI and related to hypoxia metabolic adaptation.
APA, Harvard, Vancouver, ISO, and other styles
2

Sukkar, Louisa. "Improving outcomes in chronic kidney disease and its associated comorbidities." Thesis, The University of Sydney, 2021. https://hdl.handle.net/2123/25667.

Full text
Abstract:
Background: Chronic kidney disease (CKD) and its associated comorbidities such as diabetes and cardiovascular disease (CVD) are major drivers of death and disability around the world. Methods: This thesis by publication aims to examine the burden of CKD and diabetes in the community and explores the ways in which this burden can be ameliorated. These aims are achieved by various methodologies. A novel comprehensive population-based data linkage study is used to estimate CKD and diabetes incidence and associations as well as assesses health service delivery of proven cardioprotective treatments to mitigate the burden of CVD. An observational extension of a randomised controlled trial (RCT) cohort of people with CKD is used to investigate the legacy effect of statins on CVD. A narrative review examines the RCT evidence for the CV and kidney protection of novel glucose lowering agents for the treatment of diabetes. Systematic review and meta-analyses are used to examine treatment options to mitigate the effect of Acute kidney injury (AKI) a precursor of CKD. Results: This research program has demonstrated the high burden of CKD and diabetes in the community and identified risk factors that can be targeted to inform health service planning and resource allocation. New data is presented that demonstrates the significant missed opportunities in the use of cardioprotective therapies for CVD prevention. A literature review of glucose lowering agents showed CV and renal protection in people with and without pre-existing CVD. A systematic review of two currently used treatments for the management and prevention of AKI found no evidence for their continued use. Conclusions: Collectively the findings of this thesis have the potential to inform the design of strategies to target and readily implement solutions to improve health outcomes in CKD and diabetes.
APA, Harvard, Vancouver, ISO, and other styles
3

Mele, Chiara. "Multifold aspects of obesity and insulin resistance: comorbidities and crosstalk with thyroid gland." Doctoral thesis, Università del Piemonte Orientale, 2018. http://hdl.handle.net/11579/102829.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Jackson, L. "Psychological factors associated with obesity." Thesis, University of Sheffield, 2016. http://etheses.whiterose.ac.uk/14241/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Barroso, Joana Barbara de Bessa. ""Obesity and inflammation: associated polymorphisms"." Master's thesis, Faculdade de Medicina da Universidade do Porto, 2008. http://hdl.handle.net/10216/23729.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Barroso, Joana Barbara de Bessa. ""Obesity and inflammation: associated polymorphisms"." Dissertação, Faculdade de Medicina da Universidade do Porto, 2008. http://hdl.handle.net/10216/23729.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

McNamara, Renae J. "Effect of water-based exercise in people with COPD with physical comorbidities." Thesis, The University of Sydney, 2014. http://hdl.handle.net/2123/13271.

Full text
Abstract:
People with chronic obstructive pulmonary disease (COPD) and physical comorbidities such as obesity, musculoskeletal, orthopaedic and neurological conditions have reduced free-living daily physical activity compared to people with COPD and healthy age-matched individuals. Less time is spent in light and moderate intensity physical activity and greater time is spent in sedentary behaviours. Water-based exercise training (WBET) may be an alternative to traditional land-based exercise training (LBET) for people with COPD and physical comorbidities (COPD+PC). Previous studies have shown positive outcomes for exercise capacity and quality of life following WBET, however these results were inconclusive given the trials were low in quality. In a prospective randomised controlled trial comparing an eight-week supervised WBET program to an equivalent eight-week supervised LBET program and a control group of no exercise training, WBET was found to be significantly more effective than LBET and no exercise training in increasing peak and endurance exercise capacity and improving aspects of quality of life in people with COPD+PC. In addition, obese participants randomised to the WBET program lost a greater amount of weight over the eight-week training period than participants in the LBET and no exercise training groups. WBET was found to be well accepted by people with COPD+PC, with no adverse events occurring during the training period. Furthermore, high satisfaction with the aquatic environment was reported. In a Cochrane review examining the effect of WBET in people with COPD, WBET was found to significantly improve exercise capacity (functional, peak and endurance exercise capacity) and quality of life compared to no exercise training. Compared to LBET, WBET was found to significantly improve endurance exercise capacity and fatigue. Limited quality evidence exists that WBET in people with COPD is safe and effective.
APA, Harvard, Vancouver, ISO, and other styles
8

Blaszczak, Alecia Marie. "Defining the Inflammatory Microenvironment of Human Adipose Tissue in Obesity and How It Contributes to the Development of Obesity-Related Comorbidities." The Ohio State University, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=osu1553601004244596.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Van, Guilder Gary Preston. "Vascular endothelial abnormalities associated with obesity." Diss., Connect to online resource, 2006. http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&res_dat=xri:pqdiss&rft_dat=xri:pqdiss:3219223.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Rizzolli, Jacqueline. "Obesidade grau III : considerações sobre complicações clínicas e tratamento cirúrgico." reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2005. http://hdl.handle.net/10183/8411.

Full text
Abstract:
A obesidade grau III ou também chamada obesidade mórbida é uma condição clínica freqüente e que vem apresentado crescimento progressivo, estando associada a elevadas taxas de morbi-mortalidade. Trata-se de uma doença de origem multifatorial, freqüentemente associada a comorbidezes, necessitando uma abordagem terapêutica que propicie redução de peso, melhora das doenças associadas e conseqüente melhora da qualidade de vida. O tratamento convencional deve ser sempre a primeira escolha, principalmente nos casos de inicio recente e sem antecedentes de tratamentos adequados prévios. A taxa de insucesso, contudo, é extremamente elevada, ocorrendo falha em mais de 90% dos casos. O tratamento cirúrgico atualmente é a alternativa com melhores resultados, porém com riscos de complicações a curto, médio e longo prazo, caso não seja realizado um rigoroso acompanhamento clinico, nutricional e psicológico em equipe multidisciplinar experiente. Esta revisão tem por objetivo discorrer sobre as morbidades associadas à obesidade grave, as opções de tratamento convencional e cirúrgico bem como riscos relacionados à persistência de um grande excesso de peso versus risco cirúrgico.<br>Morbid obesity is a frequent disease with a progressive increase in incidence and associated with high morbid and mortality rates. It is a multifactorial disease, and is usually associated with comorbidities. It is necessary specific treatment to reduce weight, to improve the comorbidities and obtain a better quality of life. The classic treatment, diet and exercise, should be the first choice, especially in cases of recent onset of severe obesity and poor quality previous treatments. Unfortunately, in more than 90% of the patients this kind of treatment will fail. Bariatric surgery is, nowadays, the best option of treatment, but has several risks of complications in the short, medium or long time followup, mostly in patients not followed by a specialized multidisciplinary team. This is a review about morbid obesity, comorbidities, options of treatment and the risks of stay severely obese versus surgical procedures.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Obesity and Associated Comorbidities"

1

McGowan, Anita Doris. Parenting styles associated with childhood obesity. National Library of Canada, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Physical Activity in the Prevention and Treatment of Obesity and Its Comorbidities (1999 Indianapolis, Ind.). American College of Sports Medicine roundtable: Physical Activity in the Prevention and Treatment of Obesity and Its Comorbidities. Lippincott Williams & Wilkins, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Hourani, Huda Mustafa Al. Nutritional factors associated with obesity in adolescent females in the United Arab Emirates. Oxford Brookes University, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Wilma, Caldwell, and Kimball Chad T, eds. Obesity sourcebook: Basic consumer health information about diseases and other problems associated with obesity, and including facts about risk factors, prevention issues, and management approaches, along with statistical and demographic data, information about special populations, research updates, a glossary, and source listings for further help and information. Omnigraphics, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Haroon, Muhammad. Co-morbidities. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198737582.003.0015.

Full text
Abstract:
Psoriatic arthritis (PsA) is a chronic, multisystem inflammatory condition where patients are at a higher risk for a number of major systemic comorbidities including cardiovascular disease, obesity, depression, uveitis, and cancer. These comorbidities which are frequently unrecognized or undertreated contribute significantly to the morbidity and mortality associated with PsA. There is emerging data further supporting the link between inflammation and cardiovascular disease. The detection and management of PsA patients with comorbidities requires a coordinated approach which is not yet clearly defined. Meanwhile, it is important to conduct periodic comprehensive assessments in our PsA patients in order to identify and monitor comorbidities. The importance of multispecialty cooperation and multidisciplinary assessment cannot be over-stated.
APA, Harvard, Vancouver, ISO, and other styles
6

Gissey, Lidia Castagneto, James R. Casella Mariolo, Geltrude Mingrone, and Francesco Rubino. Metabolic surgery and depression. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198789284.003.0012.

Full text
Abstract:
The incidence of obesity is rising worldwide and so are its comorbidities: type-2 diabetes mellitus (T2DM), dyslipidaemia, hypertension, cardiovascular disease, sleep apnoea, and depression. Bariatric/metabolic surgery has established itself over the past several years as an effective treatment not only for morbid obesity but also for its associated morbidities. The effects of bariatric/metabolic surgery on depression are controversial, with some studies showing improvement and others demonstrating a worsening. However, a major drawback of these studies is that they do not compare patients with the same baseline psychiatric disorders. In fact, mild to severe depressive symptoms are observed in most candidates for bariatric/metabolic surgery. Preoperative evaluation of the patient’s mental state would enable identification of the appropriate interventions, enhancing long-term compliance and weight maintenance. It could also leverage psychological support in case the patient’s disorder relapses postoperatively. Preoperative evaluation should detect potential psychological contraindications to surgery, such as severe eating disorders.
APA, Harvard, Vancouver, ISO, and other styles
7

Nutritional Pathophysiology of Obesity and its Comorbidities. Elsevier, 2017. http://dx.doi.org/10.1016/c2014-0-04074-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Pediatric Overweight and Obesity: Comorbidities, Trajectories, Prevention and Treatments. Springer International Publishing AG, 2023.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Nutritional Pathophysiology of Obesity and Its Comorbidities: A Case-Study Approach. Elsevier Science & Technology Books, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ettinger, Susan. Nutritional Pathophysiology of Obesity and Its Comorbidities: A Case-Study Approach. Elsevier Science & Technology Books, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Obesity and Associated Comorbidities"

1

Emmanuel, Julian J., and Simon W. Coppack. "Health Consequences–Obesity Associated Comorbidities." In Obesity, Bariatric and Metabolic Surgery. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-04343-2_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Adebibe, Miriam, and Simon W. Coppack. "Obesity-Associated Comorbidities: Health Consequences." In Obesity, Bariatric and Metabolic Surgery. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-030-60596-4_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Adebibe, Miriam, and Simon W. Coppack. "Obesity-Associated Comorbidities: Health Consequences." In Obesity, Bariatric and Metabolic Surgery. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-54064-7_4-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ghouri, Nazim, Peter Clifton, Angela M. Craigie, et al. "Consequences and comorbidities associated with obesity." In Advanced Nutrition and Dietetics in Obesity. John Wiley & Sons, Ltd, 2017. http://dx.doi.org/10.1002/9781118857991.ch2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Hwang, Janice Jin, George Blackburn, and Christos S. Mantzoros. "Long-Term Impact of Weight Loss on Obesity and Obesity-Associated Comorbidities." In Nutrition and Metabolism. Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-453-1_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Olbers, Torsten, and Suzanne Hedberg. "Resolution of Obesity Associated Comorbidities (Diabetes, Hypertension, Sleep Apnoea, and Metabolic Syndrome) Following Bariatric Surgery." In Obesity, Bariatric and Metabolic Surgery. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-04343-2_56.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Salgaonkar, Hrishikesh, Alistair Sharples, Kanagaraj Marimuthu, Vittal Rao, and Nagammapudur Balaji. "One Anastomosis Gastric Bypass (OAGB)." In Mastering Endo-Laparoscopic and Thoracoscopic Surgery. Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-3755-2_43.

Full text
Abstract:
AbstractOne-anastomosis gastric bypass is an attractive option in the armament of a Bariatric surgeon. A relatively simple procedure, it has been effective in inducing weight loss and resolution of obesity-associated comorbidities. Easy technique, shorter operative times, and low complication rates make it an attractive alternative option, particularly in super-obese individuals. While concerns remain regarding the long-term safety profile with regards to biliary reflux, risk of esophagogastric malignancies, and marginal ulcer. For the scope of this chapter, our focus will be on the advent of the concept, the surgical technique, and tips and tricks.
APA, Harvard, Vancouver, ISO, and other styles
8

Fierabracci, Paola, Anna Tamberi, and Ferruccio Santini. "Obesity-Related Comorbidities." In Minimally Invasive Bariatric and Metabolic Surgery. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-15356-8_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Fiori, Cintia Zappe, Denis Martinez, and Alicia Carissimi. "Obesity and Comorbidities." In Mechanical Ventilation in the Critically Ill Obese Patient. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-49253-7_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Simsek, Cem, and Christopher C. Thompson. "Obesity-Related Comorbidities." In Bariatric Endoscopy. Springer Nature Switzerland, 2024. https://doi.org/10.1007/978-3-031-70004-0_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Obesity and Associated Comorbidities"

1

Sabari, Alauddin, Mithila Farjana, Md Habibur Rahman, Md Muminur Rahman Sonic, and Mohammad Ashraful Islam. "Comprehensive biomarkers analytics web API reveals Comorbidities between Obesity and Skin Cancer." In 2024 IEEE International Conference on Computing, Applications and Systems (COMPAS). IEEE, 2024. https://doi.org/10.1109/compas60761.2024.10796236.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

He, Min, Jingsong Dong, and Dean Ta. "Low-Intensity Pulsed Ultrasound Improved the obesity-Associated Cardiac Dysfunction in Mice." In 2024 IEEE Ultrasonics, Ferroelectrics, and Frequency Control Joint Symposium (UFFC-JS). IEEE, 2024. https://doi.org/10.1109/uffc-js60046.2024.10794007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Uddin, Md Ashiq, and Md Humayun Kabir. "Comorbidities and Associated Genes Finding for Diabetes Affected Venous Blood Cell by Analyzing Gene Expression Data." In 2024 International Conference on Recent Progresses in Science, Engineering and Technology (ICRPSET). IEEE, 2024. https://doi.org/10.1109/icrpset64863.2024.10955951.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Dias, Renan Italo Rodrigues, Natália Henriques da Fonseca Araújo, State Guedes de Souza Chaves Oliveira, et al. "Association of bariatric surgery in reducing complications resulting from obesity." In V Seven International Multidisciplinary Congress. Seven Congress, 2024. http://dx.doi.org/10.56238/sevenvmulti2024-109.

Full text
Abstract:
This study investigates the association of bariatric surgery in reducing complications resulting from obesity. Obesity is a globally prevalent health condition, associated with several complications that negatively impact quality of life and increase the risk of chronic diseases. The systematic review of scientific literature identifies clinical studies and systematic reviews that explore the effects of bariatric surgery in reducing obesity-related complications. The compiled results consistently demonstrate the effectiveness of bariatric surgery in improving clinical outcomes, including reducing comorbidities associated with obesity, such as type 2 diabetes, high blood pressure and dyslipidemia. The analysis highlights the positive influence of bariatric surgery on sustained weight loss, providing metabolic and cardiovascular benefits. Furthermore, the favorable impacts on quality of life, psychosocial function and reduced risk of specific surgical complications are discussed.
APA, Harvard, Vancouver, ISO, and other styles
5

Hojs, Radovan, Robert Ekart, Sebastjan Bevc, and Nina Vodošek Hojs. "Obesity and cardionephrology – guidance on the management." In 7th International Congress of Cardionephrology KARNEF 2025. Punta Niš, 2025. https://doi.org/10.46793/karnef25.204h.

Full text
Abstract:
There is a pandemic of obesity worldwide. There is compelling evidence that obesity is associated with chronic kidney disease (CKD). Studies have shown that high body mass index is strongly related to the risk of CKD, progression of CKD and end-stage renal disease, also after adjustment for age, sex, race, smoking status, comorbidities, and laboratory tests. Obesity increases the risk of death in people without CKD. In non-dialysis-dependent CKD patients, the association between body-mass index and weight with mortality is controversial. In end-stage renal disease patients, obesity is paradoxically associated with better survival. Management of obesity in CKD patients includes life-style interventions, pharmacotherapy and bariatric surgery. In the last two years a long-acting glucagon like peptide-1 (GLP-1) receptor agonist and GLP-1 and glucose-dependent insulinotropic polypeptide receptor agonist were shown to be effective in managing weight loss in the general population. The last studies provided clear evidence of kidney and cardiovascular protection with GLP-1 receptor agonists in patients with type 2 diabetes and CKD, and also in overweight/obese patients with CKD without diabetes.
APA, Harvard, Vancouver, ISO, and other styles
6

Melo, Heloí Bruna Ribeiro de, and Anderson Barbosa Baptista. "Research on the effects of weight reduction on gut microbiota diversity in post-bariatric patients." In II SEVEN INTERNATIONAL MEDICAL AND NURSING CONGRESS. Seven Congress, 2023. http://dx.doi.org/10.56238/iicongressmedicalnursing-019.

Full text
Abstract:
Obesity has been studied as a worldwide epidemic in constant growth in recent decades. Bariatric surgery, in its various modalities, offers better life prospects for these patients. Basically these surgeries reduce the capacity of the gastric volume, controlling the food intake and consequently the weight reduction. Good habits can arise after weight loss, such as physical activity practices and balanced diet. This new lifestyle, and the remission of possible comorbidities associated with obesity, can alter the gut microbiota. The symbiotic relationship between these bacteria residing in the Gastrointestinal Tract (GIT), offer several benefits to man, such as: protection against infections, blocking colonization of pathogenic bacteria, pH control, enzymatic activities, absorption of nutrients such as ions and action in the production of some vitamins.
APA, Harvard, Vancouver, ISO, and other styles
7

Novais, Aurea Maria Lago, Beatriz Santos Rogério, and Renan Carvalho Castello Branco. "Impact of previous comorbidities in stroke patients with high risk of obstructive sleep apnea: a transversal study." In XIV Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2023. http://dx.doi.org/10.5327/1516-3180.141s1.618.

Full text
Abstract:
Introduction: Obstructive sleep apnea (OSA) is a disease of upper airways well associated in literature with stroke through diverse mechanisms. Despite that, it still is not clear the impact of the regular diseases in the context of high risk of OSA and stroke. Objectives: This study aims to elucidate the impact of previous comorbidities in imediate outcomes (hospitalization time, CTI time, hemorragic transformation,death, infection and delirium during hospitalization) of patients with high/moderate risk of OSA and stroke. Methods: We performed a transversal study, part of a cohort of stroke patients. Patients were evaluated of risk of OSA with STOP-BANG and SOS scores. Data of previous comorbidities (obesity, alcoholism, smoking, hypertension, diabetes, renal disfunction, dyslipidemia, asthma, atrial fibrillation – AF, heart failure, previous Rankin and sleep disorder) were analysed with T test or Mann-Whitney and they were submitted to multivariate analysis with logistic regression (considering P &lt; 0.05). Results: We obtained 118 patients (hospitalization time 15.41 ± 15.16; CTI time 1.87 ± 5.02). Considering hospitalization time, we had previous Rankin (P = 0.1), AF (P = 0.1) and dyslipidemia (P = 0.07); to CTI time, we had dyslipidemia (P = 0.04); to hemorragic transformation, we had asthma (P = 0.03) and smoking (P = 0.05); to death, we had alcoholism (P = 0.1) and renal insufficiency (P = 0.07). To infection, we had previous Rankin (P = 0.002), diabetes (P = 0.009) and renal insufficiency (P &lt; 0.001); to delirium, we had previous Rankin (P = 0.007), obesity and sleep disorder (P = 0.07), diabetes (P = 0.1) and renal insufficiency (P &lt; 0.001). In multivariate analysis, renal disfunction to infection were significant (P = 0.02; odds ratio = 2.34 confidence interval 1.70- 3.23). Conclusion: Renal disfunction appeared to be important in most of outcomes, and the only significant in multivariate analysis.Conditions that affect metabolism showed importance, that lead us to better control renal and metabolic disorders.
APA, Harvard, Vancouver, ISO, and other styles
8

Firmanurulita, Fadhila, Agus Kristiyanto, and Hanung Prasetya. "Association between Overweight and Hypertension in Adolescents: A Meta-Analysis." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.01.63.

Full text
Abstract:
Background: The upward trend in adolescent hypertension is widely attributed to the adolescent overweight and obesity epidemic. Because of their high-risk status, intervention in overweight adolescents with associated comorbidities, such as hypertension, should be considered. The purpose of this study was to examine association between overweight and hypertension in adolescents. Subjects and Method: This was a meta-analysis and systematic review. The articles were obtained from PubMed, Springer Link, and Google Scholar databases, which published from 2006 to 2020. Keywords used “hypertension” AND “adolescents” AND” obesity” AND “risk factor of obesity” AND “cross-sectional” AND “adjusted odds ratio”. The inclusion criteria were full-text, using English language, and reporting Odds ratio. The study population was adolescents. The intervention was overweight with comparison non overweight. The study outcome was hypertension. The articles were reviewed by PRISMA diagram and analyzed by RevMan 5.3. Results: 8 articles from Ethiopia, Spanyol, Canada, Taiwan, Lithuania, United States, and Malaysia were met criteria. The data analysis found low heterogeneity between groups (I2= 40%; p=0.110), so it used fixed effect model. This meta-analysis study reported that overweight increases the risk of hypertension in adolescents (aOR= 3.32; 95% CI= 3.02 to 3.66; p&lt;0.001). Conclusion: Overweight increases the risk of hypertension in adolescents. Keywords: overweight, hypertension, adolescents Correspondence: Fadhila Firmanurulita. Masters Program in Public Health, Universitas Sebelas Maret. Jl. Ir. Sutami 36A, Surakarta 57126, Central Java. Email: missdhila@gmail.com. Mobile: 085740045026.
APA, Harvard, Vancouver, ISO, and other styles
9

Oliveira, Ana Gabriela Caldas, Natália Helena Valleta, Klayton Henrique Morais Ribeiro, et al. "From diagnosis to beginning breast cancer treatment: A study about time in a reference private hospital in São Luís, MA, Brazil." In Brazilian Breast Cancer Symposium 2023. Mastology, 2023. http://dx.doi.org/10.29289/259453942023v33s1053.

Full text
Abstract:
Objective: The objective of this study was to determine the time interval from diagnosis to initiation breast cancer treatment and to investigate factors associated with its delay. Methodology: This is an observational, descriptive, and retrospective study with analysis of medical records between January 2015 and December 2019, carried out in a private oncology referral hospital in São Luís, MA. Patients diagnosed with breast cancer (International Classification of Diseases-10 C50) were included. A total of 21 variables of epidemiological, clinical, and tumor characteristics were analyzed. The absolute and relative frequencies of categorical and numerical variables were calculated. The chi-square test was performed to compare categorical variables, and the Student’s t-test was used to compare numerical variables. The significance level was p&lt;0.05. Results: There were 112 cases analyzed, 100% female, and 82.1% started treatment within 60 days of diagnosis. The mean time from diagnosis to treatment was 42.5 days (SD±24.3), and the median was 39 days. The year 2017 presented the majority of diagnosed cases (24.1%). The mean age at diagnosis was 51.9 years (SD±12.7), and most were 60 years or older (29.7%). In 82.4% of the cases, the tumor was diagnosed at an early stage, and most were luminal A and B tumors (52.8%). In 64.4% of the cases, the treatment was started with surgery. Factors related to the delay in starting treatment were obesity and starting with surgery (p=0.007). Conclusion: Our results are similar to those of developed countries. In the population studied, the factors related to delay were obesity and starting treatment with surgery. Possible factors that contribute to these results would be the bureaucracy involved in the authorization of private health plans, the difficulty of navigating patients through the hospital system, and the comorbidities associated with obesity.
APA, Harvard, Vancouver, ISO, and other styles
10

Lima, Juliana Ferreira de, Rebecca Correia de Oliveira, Antônio Carlos Toshihiro Nisida, Ricardo Faure, and Luis Henrique Gebrim. "RELATIONSHIP BETWEEN BODY MASS INDEX (BMI) AND SURGICAL COMPLICATIONS AFTER BREAST ONCOLOGICAL SURGERY." In Scientifc papers of XXIII Brazilian Breast Congress - 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s1068.

Full text
Abstract:
Introduction: Obesity is a multifactorial chronic disease that can predispose to several comorbidities, including breast cancer. The Department of Health estimates the number of overweight people in Brazil is 65%. The relationship between weight and height (BMI, Body Mass Index) has been used by WHO to assess the degree of obesity in the population. Breast cancer is responsible for more than 8,000 deaths each year in Brazil. Despite advances in systemic treatment, surgery is one of the main treatments used, and obesity is a relevant factor that worsens the oncological prognosis and is predictive of perioperative complications. Objectives: The aim of this study is to assess the relationship between obesity and surgical complications in 5,657 breast cancer patients undergoing surgical treatment (conservative or radical) at Pérola Byington Hospital. Methods: A retrospective, cross-sectional study was carried out with 5,657 patients undergoing surgical treatment (conservative or radical) by the Braziliann Unified Health System (SUS) at the Women’s Health Reference Center at Hospital Pérola Byington from January 2011 to December 2019. Data were collected from the medical records of the institution. The patients were divided into six groups according to BMI=W/H2 (25), followed by hematoma, diagnosed in 72 patients, 59.7% overweight women. The third most common complication was infection of the surgical site in only 19 patients (0.3%), with 78.9% in overweight women. This fact can be explained by inadequate perfusion, deficiency of macro and micronutrients and hypoxia that impairs collagen synthesis, resulting in poor healing, causing dehiscence. From these data presented, it is possible to infer thatcomplications such as seroma, hematoma, infection of the surgical wound, dehiscence, and even loss of the surgical flap are strongly associated with increased body weight. Conclusions: We came to the conclusion that the increase in body weight, especially in patients with a BMI&gt; 25, is an unfavorable factor for the occurrence of surgical complications in patients with breast cancer, and it is essential to provide guidance on the risks of complications in the preoperative evaluation for adjusting the best surgical procedure and mainly for considering late reconstruction.
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Obesity and Associated Comorbidities"

1

Palacios-Meneses, Blessing Itzel, Sarah Bak-Geller Corona, Araceli Jiménez-Mendoza, and Sandra Hernández-Corral. Body image in women undergoing bariatric surgery: a systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.4.0089.

Full text
Abstract:
Review question / Objective: The purpose of this study is to present a synthesis of knowledge about the effects of bariatric surgery on the body image of women after surgical intervention. Condition being studied: Along with the increase in obesity rates, the number of surgical procedures for its treatment is also growing. While for healthcare professionals, the main indicator of success of bariatric surgery is weight loss and the control/remission of comorbidities associated with obesity, for those who undergo such intervention, their expectations go beyond that, as excess wight has affected their psychosocial spheres, generating disorders of body image, low self-esteem, anxiety, eating disorders, isolations, among others. Therefore, evaluating the effect of bariatric surgery on body image is a key factor in determining the success of surgery from the user’s perspective. It is necessary to have synthesis of knowledge considering sociocultural difference, objective measurement through instruments to incorporate them into long-term clinical follow-up.
APA, Harvard, Vancouver, ISO, and other styles
2

Jaganathan Geethalakshmi, Kruthica, Iyshwarya Bhaskar Kalarani, and Ramakrishnan Veerabathiran. Metabolic complications associated with lipodystrophic obesity and diabetes. Peeref, 2022. http://dx.doi.org/10.54985/peeref.2211p4354869.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Litwak, León. Diabetes: news from the ADA 2024 Congress. Lugones Editorial, 2024. http://dx.doi.org/10.47196/0584.

Full text
Abstract:
The detection and prevention of diabetes, its diagnosis and treatment, its associated complications and comorbidities, and the role of artificial intelligence were some of the topics of the ADA 2024 Congress.
APA, Harvard, Vancouver, ISO, and other styles
4

Khadan, Jeetendra, Nekeisha Spencer, Eric Strobl, and Theophiline Bose-Duker. Socioeconomic Factors Associated with Being Overweight or Obese in Suriname. Inter-American Development Bank, 2021. http://dx.doi.org/10.18235/0003348.

Full text
Abstract:
This paper applies probit regression models to a nationally representative household survey dataset collected in 2016-2017 to analyze the relationships between various socio-demographic variables and adult Body Mass Index (BMI) in Suriname. Our results indicate that women, the elderly, and couples either married and/or living together are more likely to be obese or overweight. As expected, this is also true for individuals who have chronic illnesses. The analysis also finds that individuals who engage in a sport or in other forms of exercise, even if modest, have lower odds of being overweight or obese. Interestingly, the findings indicate that individuals who benefit from government social safety net programs are less likely to be associated with being overweight or obese. The results of this study have implications for the adjustment of current Surinamese nutritional guidelines as well as the design and implementation of targeted obesity-reduction policies that recognize that being overweight is influenced by various characteristics. Although the results are country-specific, they have the potential to influence action in all countries in the Caribbean that lack policies to address obesity.
APA, Harvard, Vancouver, ISO, and other styles
5

Huang, Hui-Bin, Yi-Bing Zhu, and Da-Xing Yu. Sarcopenic obesity is significantly associated with poorer overall survival after liver transplantation: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2024. http://dx.doi.org/10.37766/inplasy2024.2.0069.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Tankelevitch, Lev, and Sarah Bunn. Sleep and Long-Term Health. Parliamentary Office of Science and Technology, 2018. http://dx.doi.org/10.58248/pb29.

Full text
Abstract:
A POSTbrief that describes the research examining the long-term health outcomes associated with disruptions to sleep and the circadian rhythm. Long-term sleep problems are associated with a range of poor health outcomes including increased risk for mental health conditions, obesity and type 2 diabetes, amongst others.
APA, Harvard, Vancouver, ISO, and other styles
7

Zafirovska, Marija, Aleksandar Zafirovski, Tadeja Rezen, and Tadeja Pintar. The Outcome of Metabolic and Bariatric Surgery in Morbidly Obese Patients with Different Genetic Variants Associated with Obesity: A Systematic Review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2024. http://dx.doi.org/10.37766/inplasy2024.7.0020.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Wang, Zhen, Alaa Al Nofal, Meera Shah, et al. Association of Digestible Carbohydrate Intake With Cardiovascular Disease, Type 2 Diabetes, Obesity, and Body Composition. Agency for Healthcare Research and Quality (AHRQ), 2025. https://doi.org/10.23970/ahrqepcsr_carbcardio.

Full text
Abstract:
Background. Epidemiological studies have shown inconsistent findings regarding the effect of dietary digestible carbohydrate intake on the risk of cardiovascular disease and type 2 diabetes (T2D). Synthesis of such evidence is important for determining the Dietary Reference Intakes (DRI) for carbohydrates, which can have consequences on incidence and morbidity of chronic conditions. Methods. Two systematic reviews were conducted, one addressing cardiovascular outcomes and the second addressing incidence of T2D, body weight, and composition. We searched several databases from January 1, 2000, to July 19, 2024, and searched gray literature. Eligible studies evaluated the outcomes of interest in healthy individuals over 2 years old and isolated the effect of digestible carbohydrate intake from other macronutrients in grams per day or percent of total energy intake. Random-effects dose-response meta-analyses were conducted when feasible. Results. The systematic review on cardiovascular outcome included 21 prospective cohort studies with 1,277,621 participants. The majority of the studies reported inadequate confounding adjustment (73%) and were deemed to have serious risks of bias (80%). No eligible studies evaluated children under 18 years. The association between digestible carbohydrate intake and cardiovascular outcomes was nonlinear and was supported by low strength of evidence. When carbohydrate intake was analyzed as the percentage of total energy intake, the risk of incident cardiovascular disease significantly increased when carbohydrate intake exceeded 65 percent total energy intake, compared with the carbohydrate intake reference level of 50 percent total energy intake. The lowest risk was at a carbohydrate intake level of 50 percent total energy intake. The risk of incident coronary heart disease increased starting at a carbohydrate intake level of 45 percent total energy intake. When carbohydrate intake was analyzed as grams per day, the risk of incident cardiovascular disease significantly increased when carbohydrate intake exceeded 300 grams per day, compared with a reference level of 300 grams per day. The lowest risk was at a carbohydrate intake level of 250 grams per day. The risk of incident coronary heart disease increased starting at 250 grams per day of carbohydrates. The nonlinear relationships were overall similar based on sex or geographic location but with variable intake range associated with the lowest risk. Higher carbohydrate intake was associated with lower levels of high-density lipoprotein-cholesterol and higher levels of triglycerides. The systematic review on diabetes and body composition included 17 studies with 497,941 participants. The majority of the studies reported inadequate confounding adjustment (79%) and were deemed to have serious risks of bias (92%). No eligible studies evaluated children under 18 years. The association between carbohydrate intake and incident T2D was nonlinear and was supported by low strength of evidence. Analyzing carbohydrate intake as a percentage of total energy intake showed a gradual reduction in the risk of incident T2D up to 45 percent total energy intake. The risk then plateaued between 45 percent and 55 percent total energy intake before rising with higher carbohydrate intake levels. Similarly, analyzing carbohydrate intake in grams per day revealed a gradually reduced risk up to 270 grams per day, followed by a plateau between 270–350 grams per day and increased risk after 350 grams per day. The evidence was insufficient to determine an association between carbohydrate intake and weight or body composition. The nonlinear relationships were overall similar based on sex but with variable intake range associated with the lowest risk. Very few studies evaluated intermediate outcomes. Conclusion. Dose-response meta-analyses suggest a nonlinear relationship between the intake of digestible carbohydrates and cardiovascular disease and incident T2D. These associations appear to be U-shaped and suggest certain ranges of carbohydrate intake that were associated with the lowest risk. Such ranges can help in establishing future DRI for carbohydrates, which can have important consequences on incidence and morbidity of chronic conditions and public health.
APA, Harvard, Vancouver, ISO, and other styles
9

hu, diangeng, Jianxin Zhao, Hao Zhang, Zhennan Gu, and Gang Wang. Fecal Microbiota Transplantation for Weight and Glycemic Control of Obesity as well as the Associated Metabolic Diseases : Meta-Analysis & Comprehensive Assessment. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.3.0084.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

MacDiarmid, Jennifer, Benjamin McCormick, and David McBey. Healthy and Sustainable Diets: Facilitators, Barriers & Consequences. University of Aberdeen, 2024. http://dx.doi.org/10.57064/2164/24101.

Full text
Abstract:
The Scottish diet is unsustainable both in terms of health and environmental impacts. Poor diets in Scotland are associated with the high prevalence of obesity and non- communicable diseases and are contributing to global warming. Moving towards eating plant-based diets can have multiple co-benefits for health and the climate, in line with government targets.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Obesity and Associated Comorbidities' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography